These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1088 related articles for article (PubMed ID: 16979397)

  • 1. Protective effect of brain-derived neurotrophic factor on pancreatic islets in obese diabetic mice.
    Yamanaka M; Itakura Y; Inoue T; Tsuchida A; Nakagawa T; Noguchi H; Taiji M
    Metabolism; 2006 Oct; 55(10):1286-92. PubMed ID: 16979397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intermittent administration of brain-derived neurotrophic factor (BDNF) ameliorates glucose metabolism and prevents pancreatic exhaustion in diabetic mice.
    Yamanaka M; Itakura Y; Ono-Kishino M; Tsuchida A; Nakagawa T; Taiji M
    J Biosci Bioeng; 2008 Apr; 105(4):395-402. PubMed ID: 18499057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the antidiabetic effects of brain-derived neurotrophic factor and thiazolidinediones in obese diabetic mice.
    Yamanaka M; Itakura Y; Tsuchida A; Nakagawa T; Noguchi H; Taiji M
    Diabetes Obes Metab; 2007 Nov; 9(6):879-88. PubMed ID: 17924870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain-derived neurotrophic factor regulates glucose metabolism by modulating energy balance in diabetic mice.
    Nakagawa T; Tsuchida A; Itakura Y; Nonomura T; Ono M; Hirota F; Inoue T; Nakayama C; Taiji M; Noguchi H
    Diabetes; 2000 Mar; 49(3):436-44. PubMed ID: 10868966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain-derived neurotrophic factor enhances glucose utilization in peripheral tissues of diabetic mice.
    Yamanaka M; Tsuchida A; Nakagawa T; Nonomura T; Ono-Kishino M; Sugaru E; Noguchi H; Taiji M
    Diabetes Obes Metab; 2007 Jan; 9(1):59-64. PubMed ID: 17199719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain-derived neurotrophic factor (BDNF) regulates glucose and energy metabolism in diabetic mice.
    Nakagawa T; Ono-Kishino M; Sugaru E; Yamanaka M; Taiji M; Noguchi H
    Diabetes Metab Res Rev; 2002; 18(3):185-91. PubMed ID: 12112936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain-derived neurotrophic factor reduces blood glucose level in obese diabetic mice but not in normal mice.
    Ono M; Ichihara J; Nonomura T; Itakura Y; Taiji M; Nakayama C; Noguchi H
    Biochem Biophys Res Commun; 1997 Sep; 238(2):633-7. PubMed ID: 9299565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic treatment with sympatholytic dopamine agonists improves aberrant beta-cell hyperplasia and GLUT2, glucokinase, and insulin immunoreactive levels in ob/ob mice.
    Jetton TL; Liang Y; Cincotta AH
    Metabolism; 2001 Nov; 50(11):1377-84. PubMed ID: 11699060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acceleration of the development of diabetes in obese diabetic (db/db) mice by nicotinamide: a comparison with its antidiabetic effects in non-obese diabetic mice.
    Piercy V; Toseland CD; Turner NC
    Metabolism; 2000 Dec; 49(12):1548-54. PubMed ID: 11145115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucagon-like peptide-1 treatment delays the onset of diabetes in 8 week-old db/db mice.
    Wang Q; Brubaker PL
    Diabetologia; 2002 Sep; 45(9):1263-73. PubMed ID: 12242459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel glucagon-like peptide-1 (GLP-1) analog (Val8)GLP-1 results in significant improvements of glucose tolerance and pancreatic beta-cell function after 3-week daily administration in obese diabetic (ob/ob) mice.
    Green BD; Lavery KS; Irwin N; O'harte FP; Harriott P; Greer B; Bailey CJ; Flatt PR
    J Pharmacol Exp Ther; 2006 Aug; 318(2):914-21. PubMed ID: 16648370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibroblast growth factor-21 improves pancreatic beta-cell function and survival by activation of extracellular signal-regulated kinase 1/2 and Akt signaling pathways.
    Wente W; Efanov AM; Brenner M; Kharitonenkov A; Köster A; Sandusky GE; Sewing S; Treinies I; Zitzer H; Gromada J
    Diabetes; 2006 Sep; 55(9):2470-8. PubMed ID: 16936195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain-derived neurotrophic factor regulates energy expenditure through the central nervous system in obese diabetic mice.
    Nonomura T; Tsuchida A; Ono-Kishino M; Nakagawa T; Taiji M; Noguchi H
    Int J Exp Diabetes Res; 2001; 2(3):201-9. PubMed ID: 12369708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogenic restoration of functional pancreatic islet cytoarchitecture in diabetes (db/db) mutant C57BL/KsJ mice: relationship to estradiol localization, systemic glycemia, and persistent hyperinsulinemia.
    Garris DR; Garris BL
    Cell Tissue Res; 2005 Feb; 319(2):231-42. PubMed ID: 15654653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of brain-derived neurotrophic factor on insulin signal transduction in the liver of diabetic mice.
    Tsuchida A; Nakagawa T; Itakura Y; Ichihara J; Ogawa W; Kasuga M; Taiji M; Noguchi H
    Diabetologia; 2001 May; 44(5):555-66. PubMed ID: 11380073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain-derived neurotrophic factor modulates glucagon secretion from pancreatic alpha cells: its contribution to glucose metabolism.
    Hanyu O; Yamatani K; Ikarashi T; Soda S; Maruyama S; Kamimura T; Kaneko S; Hirayama S; Suzuki K; Nakagawa O; Nawa H; Aizawa Y
    Diabetes Obes Metab; 2003 Jan; 5(1):27-37. PubMed ID: 12542722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain-derived neurotrophic factor bound with lecithin derivative showed a markedly enhanced pharmacological potency due to its potent cell membrane affinity followed by prolonged MAPK activation.
    Igarashi R; Nakayama T; Takenaga M; Ichinohe M; Yamaguchi Y; Matsumoto K; Kitagawa A; Nakamura N; Kawai S; Nakagawa T; Taiji M; Nakayama C; Mizushima Y
    J Control Release; 2005 Feb; 102(2):463-73. PubMed ID: 15653164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-obesity and anti-diabetic effects of brain-derived neurotrophic factor in rodent models of leptin resistance.
    Nakagawa T; Ogawa Y; Ebihara K; Yamanaka M; Tsuchida A; Taiji M; Noguchi H; Nakao K
    Int J Obes Relat Metab Disord; 2003 May; 27(5):557-65. PubMed ID: 12704399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histological, immunocytochemical, and morphometrical analyses of pancreatic islets in the BSB mouse model of obesity.
    Slavin BG; Zarow C; Warden CH; Fisler JS
    Anat Rec (Hoboken); 2010 Jan; 293(1):108-16. PubMed ID: 19798700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucose and ATP levels in pancreatic islet tissue of normal and diabetic rats.
    Matschinsky FM; Pagliara AS; Stillings SN; Hover BA
    J Clin Invest; 1976 Nov; 58(5):1193-200. PubMed ID: 136453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 55.